Brief: Medrx commences additional trial of phase I clinical trial for MRX-4TZT
Sept 1 (Reuters) - Medrx Co Ltd 4586.T
* Says it commences additional trial of phase I clinical
trial for spastic paralysis treatment plasters(MRX-4TZT) in U.S.
Source text in Japanese: https://goo.gl/kJWhKv
Further company coverage: 4586.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: Tingting.liu@thomsonreuters.com@reuters.net))